ISPOR 17th Annual International Meeting
June 2-6, 2012, Washington, DC, USA

Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?

Médicaments Issus des Biotechnologies : Différencier Les Prix selon la Valeur

Comments on : Performance-Based Risk-Sharing Arrangements - Good practice for design, implementation and evaluation. An ISPOR Task force review

EUnetHTA : Draft Guidelines - Endpoints used for REA of pharmaceuticals HEALTH-RELATED QUALITY OF LIFE and UTILITY MEASURES

Home

Publications 1990-1994

Decazes J.M., Launois R, Vercken JB.

Cost-effectiveness of sparfloxacin in community-acquired pneumonia

5th International Symposium on New Quinolones. Singapore, August 25-27, 1994.